Skip to main content
. Author manuscript; available in PMC: 2023 Feb 3.
Published in final edited form as: J Med Econ. 2021 Jan-Dec;24(1):1060–1069. doi: 10.1080/13696998.2021.1965732

Table 2.

Cost-Effectiveness Analysis Comparing Vaccination to No Intervention to Address the U.S. COVID-19 Pandemic.

Comparator Cost ($) dCost ($) Effectiveness (QALYs) dEffectiveness (dQALYs) ICER ($/QALY) Program Cost ($ Billions) Budget Impact ($ per person)
Do Nothing 102 - 0.879 - - 33.797 102
Vaccination 86 −16 0.899 0.020 Dominates 13.042 40

Definitions: ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year; dCost, difference in cost; dEffectiveness, difference in effectiveness; dQALYs, difference in QALYs

Dominates indicates that the alternative is preferred at a lower cost and higher effectiveness relative to “Do Nothing.”